$SKIN
Beauty Health Co

2021 Q2 Form 10-Q Financial Statement

#000181809321000034 Filed on August 13, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $66.51M $14.12M
YoY Change 371.15%
Cost Of Revenue $19.26M $9.840M
YoY Change 95.7%
Gross Profit $47.25M $4.276M
YoY Change 1005.03%
Gross Profit Margin 71.05% 30.29%
Selling, General & Admin $70.62M $11.60M
YoY Change 508.86%
% of Gross Profit 149.45% 271.23%
Research & Development $2.988M $597.0K
YoY Change 400.5%
% of Gross Profit 6.32% 13.96%
Depreciation & Amortization $700.0K $600.0K
YoY Change 16.67%
% of Gross Profit 1.48% 14.03%
Operating Expenses $73.60M $12.20M
YoY Change 503.56%
Operating Profit -$26.35M -$7.919M
YoY Change 232.78%
Interest Expense -$2.060M -$5.667M
YoY Change -63.65%
% of Operating Profit
Other Income/Expense, Net -$114.9M -$5.530M
YoY Change 1977.67%
Pretax Income -$141.2M -$13.45M
YoY Change 950.25%
Income Tax -$1.900M -$3.100M
% Of Pretax Income
Net Earnings -$139.4M -$10.40M
YoY Change 1240.56%
Net Earnings / Revenue -209.57% -73.65%
Basic Earnings Per Share -$1.52 -$0.30
Diluted Earnings Per Share -$1.52 -$0.30
COMMON SHARES
Basic Shares Outstanding 91.80M shares 34.48M shares
Diluted Shares Outstanding 91.80M shares 34.48M shares

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $101.5M
YoY Change
Cash & Equivalents $101.5M $14.62M
Short-Term Investments
Other Short-Term Assets $4.804M
YoY Change
Inventory $23.76M
Prepaid Expenses $4.804M
Receivables $40.13M
Other Receivables $4.279M
Total Short-Term Assets $174.4M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $10.11M
YoY Change
Goodwill $103.1M $98.49M
YoY Change 4.68%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.489M
YoY Change
Total Long-Term Assets $168.1M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $174.4M
Total Long-Term Assets $168.1M
Total Assets $342.5M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $17.33M
YoY Change
Accrued Expenses $21.40M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $39.49M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $1.767M
YoY Change
Total Long-Term Liabilities $1.767M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $39.49M
Total Long-Term Liabilities $1.767M
Total Liabilities $326.4M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$186.3M
YoY Change
Common Stock $13.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $16.07M -$20.51M
YoY Change
Total Liabilities & Shareholders Equity $342.5M
YoY Change

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$139.4M -$10.40M
YoY Change 1240.56%
Depreciation, Depletion And Amortization $700.0K $600.0K
YoY Change 16.67%
Cash From Operating Activities -$31.43M -$11.63M
YoY Change 170.15%
INVESTING ACTIVITIES
Capital Expenditures -$4.980M -$1.425M
YoY Change 249.47%
Acquisitions
YoY Change
Other Investing Activities -$4.139M
YoY Change
Cash From Investing Activities -$9.119M -$1.425M
YoY Change 539.93%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 133.0M 20.54M
YoY Change 547.85%
NET CHANGE
Cash From Operating Activities -31.43M -11.63M
Cash From Investing Activities -9.119M -1.425M
Cash From Financing Activities 133.0M 20.54M
Net Change In Cash 92.50M 7.479M
YoY Change 1136.85%
FREE CASH FLOW
Cash From Operating Activities -$31.43M -$11.63M
Capital Expenditures -$4.980M -$1.425M
Free Cash Flow -$26.45M -$10.21M
YoY Change 159.07%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001818093
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39565
dei Entity Registrant Name
EntityRegistrantName
The Beauty Health Company
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-1908962
dei Entity Address Address Line1
EntityAddressAddressLine1
2165 Spring Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Long Beach
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90806
dei City Area Code
CityAreaCode
800
dei Local Phone Number
LocalPhoneNumber
603-4996
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
133419152 shares
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
101467000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9486000 USD
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2681000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2032000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
40128000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
18576000 USD
CY2021Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4804000 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3220000 USD
CY2021Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4279000 USD
CY2020Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4611000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
23762000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
23202000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
103100000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
174440000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
59095000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10113000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9191000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
51884000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
50935000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
98531000 USD
CY2021Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
482000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
270000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2489000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4813000 USD
CY2021Q2 us-gaap Assets
Assets
342508000 USD
CY2020Q4 us-gaap Assets
Assets
222835000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
17328000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
18485000 USD
CY2021Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1313000 USD
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
18327000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9475000 USD
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3073000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2458000 USD
CY2021Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
764000 USD
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 USD
CY2021Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
0 USD
CY2020Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
512000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
39492000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
30930000 USD
CY2021Q2 skin Reverse Recapitalization Contingent Consideration Liability Noncurrent
ReverseRecapitalizationContingentConsiderationLiabilityNoncurrent
126000000 USD
CY2020Q4 skin Reverse Recapitalization Contingent Consideration Liability Noncurrent
ReverseRecapitalizationContingentConsiderationLiabilityNoncurrent
0 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1767000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1854000 USD
CY2021Q2 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
0 USD
CY2020Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
216024000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3987000 USD
CY2021Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
157866000 USD
CY2020Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
0 USD
CY2021Q2 us-gaap Liabilities
Liabilities
326438000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
252795000 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
320000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
320000000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
125439779 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
125439779 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35501743 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35501743 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
13000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
4000 USD
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
202352000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13952000 USD
CY2021Q2 us-gaap Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock
ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock
0 USD
CY2020Q4 us-gaap Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock
ReceivableFromShareholdersOrAffiliatesForIssuanceOfCapitalStock
554000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-39000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
242000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-186256000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-43604000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
16070000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-29960000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
342508000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
222835000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
66508000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14116000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
114050000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46652000 USD
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
19257000 USD
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
9840000 USD
us-gaap Cost Of Revenue
CostOfRevenue
35059000 USD
us-gaap Cost Of Revenue
CostOfRevenue
23447000 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
47251000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
4276000 USD
us-gaap Gross Profit
GrossProfit
78991000 USD
us-gaap Gross Profit
GrossProfit
23205000 USD
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
26214000 USD
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
6186000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
43309000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
23883000 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2988000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
597000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4440000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1972000 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
44402000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5412000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
55213000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12605000 USD
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
73604000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
12195000 USD
us-gaap Operating Expenses
OperatingExpenses
102962000 USD
us-gaap Operating Expenses
OperatingExpenses
38460000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-26353000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7919000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-23971000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-15255000 USD
CY2021Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-2060000 USD
CY2020Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-5667000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-7759000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-9817000 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4307000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
56000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4314000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
61000 USD
CY2021Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
72027000 USD
CY2020Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
72027000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2021Q2 skin Reverse Recapitalization Contingent Consideration Change In Amount Of Contingent Consideration Liability
ReverseRecapitalizationContingentConsiderationChangeInAmountOfContingentConsiderationLiability
36525000 USD
CY2020Q2 skin Reverse Recapitalization Contingent Consideration Change In Amount Of Contingent Consideration Liability
ReverseRecapitalizationContingentConsiderationChangeInAmountOfContingentConsiderationLiability
0 USD
skin Reverse Recapitalization Contingent Consideration Change In Amount Of Contingent Consideration Liability
ReverseRecapitalizationContingentConsiderationChangeInAmountOfContingentConsiderationLiability
36525000 USD
skin Reverse Recapitalization Contingent Consideration Change In Amount Of Contingent Consideration Liability
ReverseRecapitalizationContingentConsiderationChangeInAmountOfContingentConsiderationLiability
0 USD
CY2021Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
24000 USD
CY2020Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
81000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-232000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-122000 USD
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-114895000 USD
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5530000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-120857000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9878000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-141248000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13449000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-144828000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25133000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1870000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3052000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2176000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5667000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-139378000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-10397000 USD
us-gaap Net Income Loss
NetIncomeLoss
-142652000 USD
us-gaap Net Income Loss
NetIncomeLoss
-19466000 USD
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-276000 USD
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-16000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-281000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-88000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-139654000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10413000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-142933000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-19554000 USD
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.52
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.52
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.58
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.58
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
91798837 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91798837 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34482179 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34482179 shares
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-5000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33309191 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63805807 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63805807 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33309191 shares
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-1208000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
26000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-9070000 USD
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-72000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-10324000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
224000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-10397000 USD
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-16000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-20513000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-29960000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
34000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-3274000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-33205000 USD
CY2021Q2 skin Stock Issued During Period Value Reverse Recapitalization
StockIssuedDuringPeriodValueReverseRecapitalization
183864000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1557000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3508000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-139378000 USD
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-276000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
16070000 USD
us-gaap Net Income Loss
NetIncomeLoss
-142652000 USD
us-gaap Net Income Loss
NetIncomeLoss
-19466000 USD
us-gaap Depreciation
Depreciation
1418000 USD
us-gaap Depreciation
Depreciation
1273000 USD
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
626000 USD
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
349000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
646000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
874000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5229000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5616000 USD
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
66000 USD
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
66000 USD
skin Write Off And Amortization Of Deferred Debt Issuance Costs
WriteOffAndAmortizationOfDeferredDebtIssuanceCosts
2806000 USD
skin Write Off And Amortization Of Deferred Debt Issuance Costs
WriteOffAndAmortizationOfDeferredDebtIssuanceCosts
701000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3542000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
250000 USD
us-gaap Amortization Of Below Market Lease
AmortizationOfBelowMarketLease
0 USD
us-gaap Amortization Of Below Market Lease
AmortizationOfBelowMarketLease
36000 USD
skin Below Market Lease Write Down
BelowMarketLeaseWriteDown
0 USD
skin Below Market Lease Write Down
BelowMarketLeaseWriteDown
383000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-25000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
4130000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
1855000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3471000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-47000 USD
skin Reverse Recapitalization Contingent Consideration Change In Amount Of Contingent Consideration Liability
ReverseRecapitalizationContingentConsiderationChangeInAmountOfContingentConsiderationLiability
36525000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
72027000 USD
skin Reverse Recapitalization Contingent Consideration Change In Amount Of Contingent Consideration Liability
ReverseRecapitalizationContingentConsiderationChangeInAmountOfContingentConsiderationLiability
0 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
us-gaap Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost
GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
-2014000 USD
us-gaap Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost
GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
0 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
21089000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-9193000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1562000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-636000 USD
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-333000 USD
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
3393000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
229000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1821000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-730000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
167000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2369000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2191000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
9047000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-6768000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-87000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
382000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
382000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-2963000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31938000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11633000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
4920000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
781000 USD
us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
273000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
105000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4707000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1320000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9119000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1425000 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
5000000 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
6500000 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
5000000 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
15000000 USD
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 USD
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
30000000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
77000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
225487000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
886000 USD
skin Proceeds From Reverse Recapitalization Transaction
ProceedsFromReverseRecapitalizationTransaction
358536000 USD
skin Proceeds From Reverse Recapitalization Transaction
ProceedsFromReverseRecapitalizationTransaction
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
133049000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20537000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
91992000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
7479000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-11000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-164000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9486000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7307000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
101467000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14622000 USD
us-gaap Interest Paid Net
InterestPaidNet
10249000 USD
us-gaap Interest Paid Net
InterestPaidNet
7261000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
96000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
97000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1440000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1242000 USD
us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
90000 USD
us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
0 USD
CY2021Q2 skin Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
653.109
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
us-gaap Use Of Estimates
UseOfEstimates
<div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates and assumptions in preparing consolidated financial statements</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preparing its consolidated financial statements in conformity with GAAP, the Company makes assumptions, estimates, and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the consolidated financial statements and the reported amounts of net sales and expenses during the reported periods. On an ongoing basis, the Company evaluates its estimates, including, among others, those related to revenue related reserves, allowance for doubtful accounts, the realizability of inventory, fair value measurements including </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">common stock, warrant liabilities and earn-out shares liability </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">valuations, useful lives of property and equipment, goodwill and finite-lived intangible assets, accounting for income taxes, stock-based compensation expense and commitments and contingencies. The Company’s estimates are based on historical experience and on its future expectations that are believed to be reasonable. The combination of these factors forms the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from its current estimates and those differences may be material.</span></div>
CY2021Q2 skin Common Stock Convertible Conversion Ratio
CommonStockConvertibleConversionRatio
1
CY2021Q2 skin Reverse Recapitalization Equity Interest Issued Or Issuable Number Of Shares
ReverseRecapitalizationEquityInterestIssuedOrIssuableNumberOfShares
7500000 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
125329053 shares
CY2021Q2 skin Reverse Recapitalization Consideration Received
ReverseRecapitalizationConsiderationReceived
783000000 USD
CY2021Q2 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
350000000 USD
CY2021Q2 skin Cash Acquired Through Reverse Recapitalization
CashAcquiredThroughReverseRecapitalization
433000000 USD
CY2021Q2 skin Reverse Recapitalization Cash Paid To Shareholders
ReverseRecapitalizationCashPaidToShareholders
368000000 USD
CY2021Q2 skin Payments Of Reverse Recapitalization Transaction Costs
PaymentsOfReverseRecapitalizationTransactionCosts
57000000 USD
CY2021Q2 skin Stock Converted Reverse Recapitalization
StockConvertedReverseRecapitalization
35501743 shares
skin Cash Acquired Through Reverse Recapitalization
CashAcquiredThroughReverseRecapitalization
433382000 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
350000000 USD
skin Reverse Recapitalization Cash Paid To Shareholders
ReverseRecapitalizationCashPaidToShareholders
367870000 USD
skin Payments Of Reverse Recapitalization Transaction Costs
PaymentsOfReverseRecapitalizationTransactionCosts
56976000 USD
skin Proceeds From Reverse Recapitalization Transaction
ProceedsFromReverseRecapitalizationTransaction
358536000 USD
CY2021Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
35000000 shares
CY2021Q2 skin Stock Issued During Period Shares Reverse Recapitalization
StockIssuedDuringPeriodSharesReverseRecapitalization
89827310 shares
CY2021Q2 skin Stock Converted Reverse Recapitalization
StockConvertedReverseRecapitalization
35501743 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54358 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
125329053 shares
CY2021Q2 skin Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
653.109
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
66508000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14116000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
114050000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46652000 USD
CY2020Q2 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
3200000 USD
CY2021Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
8816000 USD
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
9335000 USD
CY2021Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
14946000 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
13867000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
23762000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
23202000 USD
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5818000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4407000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10113000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9191000 USD
CY2021Q2 us-gaap Depreciation
Depreciation
700000 USD
CY2020Q2 us-gaap Depreciation
Depreciation
600000 USD
us-gaap Depreciation
Depreciation
1400000 USD
us-gaap Depreciation
Depreciation
1300000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
100782000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
48898000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
51884000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
93978000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
43043000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
50935000 USD
CY2021Q2 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
3000000.0 USD
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
6400000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
700000 USD
CY2020Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
400000 USD
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
5900000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
98531000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
98520000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
4766000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-197000 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-27000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
103100000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
98493000 USD
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
4300000 USD
CY2021Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
100000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
500000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1900000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2200000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3100000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5700000 USD
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0132
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0150
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.227
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.225
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
100000 USD
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
skin Effective Income Tax Rate Reconciliation Cares Act Amount
EffectiveIncomeTaxRateReconciliationCARESActAmount
-200000 USD
CY2021Q2 skin Income Tax Federal Refund Estimate Net Operating Loss Carryback Cares Act
IncomeTaxFederalRefundEstimateNetOperatingLossCarrybackCARESAct
4500000 USD
skin Cares Act Change In Interest Expense Limitations Income Tax Benefit
CARESActChangeInInterestExpenseLimitationsIncomeTaxBenefit
1200000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
1400000 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
7793600 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
7793600 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
13.41
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
13.41
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3500000 USD
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3500000 USD
skin Reverse Recapitalization Equity Interest Issued Or Issuable Number Of Shares
ReverseRecapitalizationEquityInterestIssuedOrIssuableNumberOfShares
7500000 shares
CY2021Q2 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
11500000 shares
CY2021Q2 skin Reverse Recapitalization Lock Up Agreement No Trade Period
ReverseRecapitalizationLockUpAgreementNoTradePeriod
P180D
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
103000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
315000 USD
CY2021Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
147000 USD
CY2020Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
7000 USD
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
247000 USD
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
103000 USD
CY2021Q2 us-gaap Accounts Receivable Related Parties
AccountsReceivableRelatedParties
374000 USD
CY2020Q4 us-gaap Accounts Receivable Related Parties
AccountsReceivableRelatedParties
250000 USD
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
320000000 shares
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
125439779 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
125439779 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35501743 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35501743 shares
CY2021Q2 skin Common Stock Voting Rights Votes
CommonStockVotingRightsVotes
1 vote
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
0 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
66508000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14116000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
114050000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46652000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-139378000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-10397000 USD
us-gaap Net Income Loss
NetIncomeLoss
-142652000 USD
us-gaap Net Income Loss
NetIncomeLoss
-19466000 USD
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
91798837 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91798837 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34482179 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34482179 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63805807 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63805807 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33309191 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33309191 shares
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.52
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.52
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.58
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.58

Files In Submission

Name View Source Status
0001818093-21-000034-index-headers.html Edgar Link pending
0001818093-21-000034-index.html Edgar Link pending
0001818093-21-000034.txt Edgar Link pending
0001818093-21-000034-xbrl.zip Edgar Link pending
ex311-10q210630.htm Edgar Link pending
ex312-10q210630.htm Edgar Link pending
ex321-10q210630.htm Edgar Link pending
ex322-10q210630.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
skin-20210630.htm Edgar Link pending
skin-20210630.xsd Edgar Link pending
skin-20210630_cal.xml Edgar Link unprocessable
skin-20210630_def.xml Edgar Link unprocessable
skin-20210630_htm.xml Edgar Link completed
skin-20210630_lab.xml Edgar Link unprocessable
skin-20210630_pre.xml Edgar Link unprocessable